Welch & Forbes’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,049	Closed	-$271K	–	376
2022 Q3	$271K	Sell	5,049 -1,243	-20%	-$66.7K	0.01%	332
2022 Q2	$351K	Hold	6,292	–	–	0.01%	311
2022 Q1	$442K	Buy	+6,292	New	+$442K	0.01%	300